These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12512697)

  • 21. Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.
    Buchstaller HP; Siebert CD; Steinmetz R; Frank I; Berger ML; Gottschlich R; Leibrock J; Krug M; Steinhilber D; Noe CR
    J Med Chem; 2006 Feb; 49(3):864-71. PubMed ID: 16451052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third generation thrombolytics for the treatment of ischemic stroke.
    Qureshi AI; Pande RU; Kim SH; Hanel RA; Kirmani JF; Yahia AM
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1729-32. PubMed ID: 12528307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A component of earthworm fibrinolytic enzyme having higher thrombolytic activity than total components in vivo].
    Zhao XY; Liu ZM; Jing TY; Wu JX; Zhao ZY
    Yao Xue Xue Bao; 2006 Nov; 41(11):1068-73. PubMed ID: 17262949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
    Pinto DJ; Orwat MJ; Koch S; Rossi KA; Alexander RS; Smallwood A; Wong PC; Rendina AR; Luettgen JM; Knabb RM; He K; Xin B; Wexler RR; Lam PY
    J Med Chem; 2007 Nov; 50(22):5339-56. PubMed ID: 17914785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
    Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
    Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of safety and efficacy of the various thrombolytic agents.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S17-24. PubMed ID: 12556739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oxadiazole derivatives showing partly antiplatelet, antithrombotic and serotonin antagonistic properties.
    Bethge K; Pertz HH; Rehse K
    Arch Pharm (Weinheim); 2005 Mar; 338(2-3):78-86. PubMed ID: 15736284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs.
    McBane RD; Leadley RJ; Baxi SM; Karnicki K; Wysokinski W
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):413-8. PubMed ID: 18096830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new class of anti-thrombosis hexahydropyrazino-[1',2':1,6]pyrido-[3,4-b]-indole-1,4-dions: design, synthesis, logK determination, and QSAR analysis.
    Liu J; Wu G; Cui G; Wang WX; Zhao M; Wang C; Zhang Z; Peng S
    Bioorg Med Chem; 2007 Sep; 15(17):5672-93. PubMed ID: 17590343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Xuesaitong drop pills on experimerntal thrombosis and thrombolysis in rats].
    Chen YH; Zhang SF; Sun JN; Wu JY; Jia ZH
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(3):253-6. PubMed ID: 17432152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
    Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
    J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New antithrombotics with an indazole structure.
    Yildiz AK; Rehse K; Stasch JP; Bischoff E
    Arch Pharm (Weinheim); 2004 Jun; 337(6):311-6. PubMed ID: 15188220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antithrombotic effects of carrot filtrates in rats and mice.
    Yamamoto J; Naemura A; Ijiri Y; Ogawa K; Suzuki T; Shimada Y; Giddings JC
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):785-92. PubMed ID: 19002045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel 1-pyrazolylpyridin-2-ones as potential anti-inflammatory and analgesic agents.
    Ismail MM; Ammar YA; El-Zahaby HS; Eisa SI; El-Sayed Barakat S
    Arch Pharm (Weinheim); 2007 Sep; 340(9):476-82. PubMed ID: 17647214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.